In patients with clinically localized Gleason 9–10 prostate cancer, dose-escalated radiotherapy confers better biochemical disease-free survival and prostate cancer-specific mortality than conventional doses, a recent study has found.
Interspinous diameter seems to be an important factor affecting the difficulty of laparoscopic surgery in patients with mid-low rectal cancer, suggesting that magnetic resonance imaging (MRI) pelvimetry is helpful in gauging the technical difficulty of rectal surgery, a recent study has found.
Magnetic resonance imaging (MRI)-targeted biopsy misses of clinically significant cancers seldom occur, but such rare cases are mostly caused by errors in lesion targeting, which underscores the importance of accurate coregistration and targeting when using software-based fusion platforms, according to a study. Moreover, some patients harbor MRI-invisible lesions, which cannot be targeted by MRI platforms.
Intracorporeal urinary diversion (ICUD) is associated with similar postoperative complication rates, reduced blood loss and shorter hospitalization vs extracorporeal urinary diversion (ECUD) in patients undergoing robotic-assisted radical cystectomy (RARC) for localized bladder cancer, data from the Asian RARC Consortium registry have shown.
Dietary intake of the common food additive nitrates and nitrites, trans fatty acids, and artificial sweeteners was associated with an increased risk of multiple cancers, according to data from the large NutriNet-Santé cohort presented at SABCS 2021.
A prolonged gap between biopsy and robot-assisted radical prostatectomy (RARP) does not significantly influence the likelihood of biochemical recurrence (BCR) in prostate cancer patients, even in those who are considered high-risk, a recent Japan study has found.
New drug applications approved by US FDA as of 01-15 December 2021 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.